Patents by Inventor Johan Nilvebrant

Johan Nilvebrant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ligand and use thereof
    Patent number: 11820802
    Abstract: The present invention is within the field of protein engineering and purification. The invention relates to a target-binding polypeptide mutant of an IgG binding polypeptide, such as Protein A, Protein G, Protein L or Protein M, comprising a metal binding motif. More closely the invention relates to an Fc binding ligand comprising an engineered protein based on the Protein A derived Z domain, to which a calcium binding EF-loop has been introduced.
    Type: Grant
    Filed: September 5, 2017
    Date of Patent: November 21, 2023
    Assignee: Cytiva BioProcess R&D AB
    Inventors: Sophia Hober, Sara Kanje, Johan Nilvebrant
  • Novel Ligand and Use Thereof
    Publication number: 20190218265
    Abstract: The present invention is within the field of protein engineering and purification. The invention relates to a target-binding polypeptide mutant of an IgG binding polypeptide, such as Protein A, Protein G, Protein L or Protein M, comprising a metal binding motif. More closely the invention relates to an Fc binding ligand comprising an engineered protein based on the Protein A derived Z domain, to which a calcium binding EF-loop has been introduced.
    Type: Application
    Filed: September 5, 2017
    Publication date: July 18, 2019
    Inventors: Sophia Hober, Sara Kanje, Johan Nilvebrant